2015 | Preliminary results of TATTON, a multi-arm phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer. | Oxnard, Geoffrey R.; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Yu, Helena Alexandra; Saka, Hideo; Horn, Leora; Goto, Koichi; Ohe, Yuichiro; Cantarini, Mireille; Frewer, Paul; Lahn, Michael; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
2023 | Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions | Piotrowska, Zofia; Tan, Daniel Shao-Weng; Smit, Egbert F; Spira, Alexander I; Soo, Ross A; Nguyen, Danny; Lee, Victor Ho-Fun; CHIH-HSIN YANG ; Velcheti, Vamsidhar; Wrangle, John M; Socinski, Mark A; Koczywas, Marianna; Janik, John E; Jones, Jeffrey; Yu, Helena Alexandra | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 5 | 2 | |